Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Anne Pizard"'
Autor:
Pierpaolo Pellicori, Blerim Mujaj, Stephane Heymans, Fozia Z Ahmed, N. Girerd, Ping Wang, Arantxa González, Hans-Peter Brunner-La-Rocca, Javier Díez, Franco Cosmi, Frank T. Edelmann, Mark R. Hazebroek, João Pedro Ferreira, Joe Cuthbert, Andrew L. Clark, Johannes Petutschnigg, Mamas A. Mamas, Roberto Latini, Job A J Verdonschot, John G.F. Cleland, Beatrice Mariottoni, Patrick Rossignol, Javed Khan, Jan A. Staessen, Burkert Pieske, Faiez Zannad, Anne Pizard, Stéphanie Grojean, Timothy Collier, Philippe Rouet
Publikováno v:
JACC: Heart Failure
JACC: Heart Failure, 2021, S2213-1779 (20), pp.30705-8. ⟨10.1016/j.jchf.2020.11.010⟩
JACC: Heart Failure, Elsevier/American College of Cardiology, 2021, S2213-1779 (20), pp.30705-8. ⟨10.1016/j.jchf.2020.11.010⟩
JACC-Heart Failure, 9(4), 268-277. ELSEVIER SCI LTD
JACC: Heart Failure, 2021, S2213-1779 (20), pp.30705-8. ⟨10.1016/j.jchf.2020.11.010⟩
JACC: Heart Failure, Elsevier/American College of Cardiology, 2021, S2213-1779 (20), pp.30705-8. ⟨10.1016/j.jchf.2020.11.010⟩
JACC-Heart Failure, 9(4), 268-277. ELSEVIER SCI LTD
OBJECTIVES This study sought to further understand the mechanisms underlying effect of spironolactone and assessed its impact on multiple plasma protein biomarkers and their respective underlying biologic pathways.BACKGROUND In addition to their bene
Autor:
Job A.J. Verdonschot, JoÃo Pedro Ferreira, Anne Pizard, Pierpaolo Pellicori, Hans-Peter Brunner La Rocca, Andrew L. Clark, Franco Cosmi, Joe Cuthbert, Nicolas Girerd, Olivia J. Waring, Michiel H.T.M. Henkens, Beatrice Mariottoni, Johannes Petutschnigg, Patrick Rossignol, Mark R. Hazebroek, John G.F. Cleland, Faiez Zannad, Stephane R.B. Heymans
Publikováno v:
Journal of Cardiac Failure
Journal of Cardiac Failure, Elsevier, 2021, S1071-9164 (21), pp.00501-7. ⟨10.1016/j.cardfail.2021.12.005⟩
Journal of Cardiac Failure, 28(5), 778-786. Churchill Livingstone Inc Medical Publishers
Journal of Cardiac Failure, Elsevier, 2021, ⟨10.1016/j.cardfail.2021.12.005⟩
Journal of Cardiac Failure, Elsevier, 2021, S1071-9164 (21), pp.00501-7. ⟨10.1016/j.cardfail.2021.12.005⟩
Journal of Cardiac Failure, 28(5), 778-786. Churchill Livingstone Inc Medical Publishers
Journal of Cardiac Failure, Elsevier, 2021, ⟨10.1016/j.cardfail.2021.12.005⟩
BACKGROUND: Adipose tissue influences the expression and degradation of circulating biomarkers. We aimed to identify the biomarker profile and biological meaning of biomarkers associated with obesity to assess the effect of spironolactone on the circ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae9c36c7a43563826b4bca6e70a19deb
https://lirias.kuleuven.be/handle/20.500.12942/715518
https://lirias.kuleuven.be/handle/20.500.12942/715518
Autor:
Emmanuel Bresso, João Pedro Ferreira, Arantxa González, Jean-Loup Machu, Céline Leroy, Stephane Heymans, Hans-Peter Brunner-La-Rocca, Marie-Dominique Devignes, Nicolas Girerd, Faiez Zannad, Javier Díez, Patrick Rossignol, Anne Pizard
Publikováno v:
Clinical Research in Cardiology
Clinical Research in Cardiology, Springer Verlag, 2020, 109, pp.22-33. ⟨10.1007/s00392-019-01480-4⟩
Clinical Research in Cardiology, Springer Verlag, 2020, 109 (1), pp.22-33. ⟨10.1007/s00392-019-01480-4⟩
Clinical Research in Cardiology, 2020, 109 (1), pp.22-33. ⟨10.1007/s00392-019-01480-4⟩
Clinical research in cardiology, 109(1), 22-33. Springer
Clinical Research in Cardiology, Springer Verlag, 2020, 109, pp.22-33. ⟨10.1007/s00392-019-01480-4⟩
Clinical Research in Cardiology, Springer Verlag, 2020, 109 (1), pp.22-33. ⟨10.1007/s00392-019-01480-4⟩
Clinical Research in Cardiology, 2020, 109 (1), pp.22-33. ⟨10.1007/s00392-019-01480-4⟩
Clinical research in cardiology, 109(1), 22-33. Springer
Background Hypertension, obesity and diabetes are major and potentially modifiable "risk factors" for cardiovascular diseases. Identification of biomarkers specific to these risk factors may help understanding the underlying pathophysiological pathwa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83f0b29ae639a0a986aa07ebff2fca3b
https://hal.inria.fr/hal-02138814
https://hal.inria.fr/hal-02138814
Autor:
Jean Loup Machu, Timothy Collier, Stuart J. Pocock, Nicolas Girerd, Arnaud Olivier, Bertram Pitt, Patrick Rossignol, Dirk J. van Veldhuisen, Karl Swedberg, Zohra Lamiral, Anne Pizard, John J.V. McMurray, Faiez Zannad
Publikováno v:
European Journal of Heart Failure. 19:1186-1197
Aims An excessive production of aldosterone influences outcome in patients with heart failure (HF) and in obese patients. Findings from laboratory studies suggest that chronic aldosterone blockade maybe more beneficial in abdominally obese HF-prone r
Autor:
Andrew L. Clark, Anne Pizard, Joost J. Leenders, Christian Bär, Mark R. Hazebroek, Timothy Collier, Anne-Cécile Huby, Job Verdonschot, Faiez Zannad, Ping Wang, Javier Díez, Alexandre Mebazaa, Florence Pinet, Jan A. Staessen, Alessandro Boccanelli, Harald Mischak, Zhenyu Zhang, Patrick Rossignol, Peter S. Sever, Stephane Heymans, Javed Butler, João Pedro Ferreira, Nicolas Vodovar, Thomas Thum, Nicolas Girerd, Naveed Sattar, Arantxa González, Daniel Levy, Roberto Latini, John G.F. Cleland, Jens Björkman, Wouter Jukema, Christian Delles
Publikováno v:
Circulation: Heart Failure, 12(5). LIPPINCOTT WILLIAMS & WILKINS
Circulation-Heart Failure, 12(5):005897. LIPPINCOTT WILLIAMS & WILKINS
Circulation-Heart Failure, 12(5):005897. LIPPINCOTT WILLIAMS & WILKINS
Background Identifying the mechanistic pathways potentially associated with incident heart failure (HF) may provide a basis for novel preventive strategies. Methods and Results To identify proteomic biomarkers and the potential underlying mechanistic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0966bda5b3e1758bdf297083ed349a5
https://doi.org/10.1161/circheartfailure.118.005897
https://doi.org/10.1161/circheartfailure.118.005897
Autor:
Lotte Jacobs, Ljupcho Efremov, João Pedro Ferreira, Lutgarde Thijs, Wen‐Yi Yang, Zhen‐Yu Zhang, Roberto Latini, Serge Masson, Nera Agabiti, Peter Sever, Christian Delles, Naveed Sattar, Javed Butler, John G. F. Cleland, Tatiana Kuznetsova, Jan A. Staessen, Faiez Zannad, Florence Pinet, Anne Pizard, Philippe Rouet, Joost Leenders, Javier Diez, Augustine Odili, Fang‐Fei Wei, Anne Newman, Lampros Papadimitrious, Marina Davoli, Gian Francesco Mureddu, Ian Ford, Wouter Jukema, David J. Stott, Neil Poulter
Publikováno v:
Journal of the American Heart Association
Journal of the American Heart Association, Wiley-Blackwell, 2017, 6 (5), pp.e005231. ⟨10.1161/JAHA.116.005231⟩
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Journal of the American Heart Association, Wiley-Blackwell, 2017, 6 (5), pp.e005231. ⟨10.1161/JAHA.116.005231⟩
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background To address the need for personalized prevention, we conducted a subject‐level meta‐analysis within the framework of the Heart “OMics” in AGEing (HOMAGE) study to develop a risk prediction model for heart failure (HF) based on routi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3cb3498b2a6cba5f4dddb75eafed334d
https://hal.archives-ouvertes.fr/hal-02267421
https://hal.archives-ouvertes.fr/hal-02267421
Preventive and chronic mineralocorticoid receptor antagonism is highly beneficial in obese SHHF rats
Autor:
Carlos Labat, Muller A, Faiez Zannad, Rosa-Maria Rodriguez-Guéant, Patrick Lacolley, Nicot N, Renaud Fay, Frederic Jaisser, Deng C, Arnaud Olivier, Leroy C, Gina Youcef, Anne Pizard, Laurent Vallar
Publikováno v:
British Journal of Pharmacology. 173:1805-1819
Background and purpose Mineralocorticoid receptor (MR) activation contributes to heart failure (HF) progression. Its overactivity in obesity is thought to accelerate cardiac remodelling and HF development. Given that MR antagonists (MRA) are benefici
Autor:
Chaohua Deng, Cécile Guillaume, Meriem Koufany, Anne Pizard, Arnaud Bianchi, Hervé Kempf, Nathalie Presle, David Moulin
Publikováno v:
Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2018, 77 (5), pp.e26-e26. ⟨10.1136/annrheumdis-2017-212003⟩
Annals of the Rheumatic Diseases, 2018, 77 (5), pp.e26-e26. ⟨10.1136/annrheumdis-2017-212003⟩
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2018, 77 (5), pp.e26-e26. ⟨10.1136/annrheumdis-2017-212003⟩
Annals of the Rheumatic Diseases, 2018, 77 (5), pp.e26-e26. ⟨10.1136/annrheumdis-2017-212003⟩
We thank Dr Chan and Dr Wen for their interest in our report1 and their resulting eLetter.2 We fully agree that, among the different components of metabolic syndrome (MetS), hypertension has very recently been brought out as a critical feature in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8416ddf54b2c87b29a94076b8a5da12d
https://hal.univ-lorraine.fr/hal-02983106
https://hal.univ-lorraine.fr/hal-02983106
Autor:
Anne Pizard, Hervé Kempf, Chaohua Deng, Arnaud Bianchi, Meriem Koufany, David Moulin, Cécile Guillaume, Nathalie Presle
Publikováno v:
Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2018, 77 (2), pp.315-316. ⟨10.1136/annrheumdis-2016-210700⟩
Annals of the Rheumatic Diseases, 2018, 77 (2), pp.315-316. ⟨10.1136/annrheumdis-2016-210700⟩
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2018, 77 (2), pp.315-316. ⟨10.1136/annrheumdis-2016-210700⟩
Annals of the Rheumatic Diseases, 2018, 77 (2), pp.315-316. ⟨10.1136/annrheumdis-2016-210700⟩
Increasing epidemiological and clinical studies suggest that metabolic syndrome (MetS) plays a role in the incidence and progression of osteoarthritis (OA).1 2 However, in absence of an appropriate MetS-associated OA experimental model,3 the MetS con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02e2e33e81d407bd886dddac08831d2a
https://hal.univ-lorraine.fr/hal-01702028
https://hal.univ-lorraine.fr/hal-01702028
Autor:
Pasquale Cocchiaro, Valeria De Pasquale, Rossella Della Morte, Simona Tafuri, Luigi Avallone, Anne Pizard, Anna Moles, Luigi Michele Pavone
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 5 (2017)
Frontiers in Cell and Developmental Biology
Frontiers in Cell and Developmental Biology
Kidney disease is worldwide the 12th leading cause of death affecting 8–16% of the entire population. Kidney disease encompasses acute (short-lasting episode) and chronic (developing over years) pathologies both leading to renal failure. Since spec